Reports for EFAVIRENZ

Ingredient

EFAVIRENZ

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
JAMP-EFAVIRENZ 600MG TABLET Actual shortage 2023-10-18 2024-02-06 207333
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524
TEVA-EFAVIRENZ 600MG TABLET Resolved 2023-06-20 2023-07-06 195858
TEVA-EFAVIRENZ 600MG TABLET Resolved 2023-04-27 2023-07-06 190767
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-04-14 2023-07-07 189653
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2022-06-03 2023-02-11 161940
JAMP-EFAVIRENZ 600MG TABLET Resolved 2022-04-06 2022-07-20 158082
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Avoided shortage 2020-12-07 2021-02-03 129766

Showing 1 to 10 of 17

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260
SUSTIVA TABLETS 600MG TABLET Discontinued 2021-06-14 2022-10-01 140887
SUSTIVA 50MG 50MG CAPSULE Discontinued 2021-06-14 2023-04-01 140884
SUSTIVA 200MG 200MG CAPSULE Discontinued 2021-06-14 2023-04-01 140881

Showing 1 to 4 of 4